71 related articles for article (PubMed ID: 26751426)
1. Factors influencing platelet reactivity in patients undergoing coronary artery bypass surgery.
Schneider DJ; Chava S
Coron Artery Dis; 2016 May; 27(3):185-90. PubMed ID: 26751426
[TBL] [Abstract][Full Text] [Related]
2. TMAO: a potential mediator of clopidogrel resistance.
Ma R; Fu W; Zhang J; Hu X; Yang J; Jiang H
Sci Rep; 2021 Mar; 11(1):6580. PubMed ID: 33753834
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery bypass grafting (CABG) induces pro-inflammatory and immunomodulatory phenotype of platelets in the absence of a pro-aggregatory state.
Hosseini E; Ahmadi J; Kargar F; Ghasemzadeh M
Microvasc Res; 2024 May; 153():104669. PubMed ID: 38360131
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysis.
D'Ascenzo F; Barbero U; Bisi M; Moretti C; Omedè P; Cerrato E; Quadri G; Conrotto F; Zoccai GB; DiNicolantonio JJ; Gasparini M; Bangalore S; Gaita F
Biomed Res Int; 2014; 2014():610296. PubMed ID: 25374889
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of mean platelet volume in patients after acute coronary syndrome.
Jakl M; Maly J
Anatol J Cardiol; 2015 Jan; 15(1):31-2. PubMed ID: 25550247
[No Abstract] [Full Text] [Related]
6. Retracted: Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9867613. PubMed ID: 37387824
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor vs clopidogrel followed by ticagrelor re-loading in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized, pharmacodynamic comparison.
Alexopoulos D; Kontoprias K; Gkizas V; Karanikas S; Ziakas A; Barampoutis N; Tsigkas G; Koutsogiannis N; Davlouros P; Patsilinakos S; Karvounis H; Hahalis G; Xanthopoulou I
Platelets; 2016 Jul; 27(5):420-6. PubMed ID: 26763727
[TBL] [Abstract][Full Text] [Related]
8. Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.
Nylander S; Schulz R
Br J Pharmacol; 2016 Apr; 173(7):1163-78. PubMed ID: 26758983
[TBL] [Abstract][Full Text] [Related]
9. Boosting the coagulation restores haemostasis in ticagrelor-treated mice.
Pehrsson S; Hansson K; Nelander K; Nylander S
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):913-919. PubMed ID: 26757017
[TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease.
Keach JW; Yeh RW; Maddox TM
Curr Atheroscler Rep; 2016 Jan; 18(1):5. PubMed ID: 26753771
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK;
Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model.
Abdel-Qadir H; Roifman I; Wijeysundera HC
CMAJ Open; 2015; 3(4):E438-46. PubMed ID: 26770967
[TBL] [Abstract][Full Text] [Related]
13. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
14. Current status of data on cangrelor.
Qamar A; Bhatt DL
Pharmacol Ther; 2016 Mar; 159():102-9. PubMed ID: 26802900
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R
J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683
[TBL] [Abstract][Full Text] [Related]
16. Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent.
De Vecchis R; Cantatrione C; Mazzei D
J Clin Med Res; 2016 Feb; 8(2):153-61. PubMed ID: 26767085
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
[TBL] [Abstract][Full Text] [Related]
18. Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Sambola A; Mutuberría M; García Del Blanco B; Alonso A; Barrabés JA; Bueno H; Alfonso F; Cequier A; Zueco J; Rodríguez-Leor O; Tornos P; García-Dorado D
PLoS One; 2016; 11(1):e0147245. PubMed ID: 26808678
[TBL] [Abstract][Full Text] [Related]
19. Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.
Arima Y; Kaikita K; Ishii M; Ito M; Sueta D; Oimatsu Y; Sakamoto K; Tsujita K; Kojima S; Nakagawa K; Hokimoto S; Ogawa H
J Thromb Haemost; 2016 Apr; 14(4):850-9. PubMed ID: 26773298
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents.
Park TK; Song YB; Ahn J; Carriere KC; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Gwon HC
Circ Cardiovasc Interv; 2016 Jan; 9(1):e002816. PubMed ID: 26755571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
